The Galien Forum USA 2020
October 29th 2020 / 10:30 am – 3:45 pm
Alexandria Center – New York City
…with top scientists, executive and thought leaders from academic and private research who offer perspectives on the most significant challenges in the global burden of disease and highlight the latest research and clinical pathways toward diagnosis, treatment, and cure.
OPENING KEYNOTE
Welcome address:
Dr. Michael Rosenblatt
Co-Chair, Galien Forum
Committee Member, Prix Galien USA
Chief Medical Officer
Flagship Pioneering, Cambridge, MA
Keynote:
Anthony S. Fauci, MD
Director
National Institute of Allergy and Infectious Diseases (NIAID)
PANEL 1
Immunology from Both Sides: Oncology and Autoimmune Disease
11:00 am – 12:00 pm
Chair:
George Yancopoulos
Founding Scientist, President & Chief Scientific Officer
Regeneron Pharmaceuticals
Panelists:
Carl H. June, MD
Director, Center for Cellular Immunotherapies
Professor of Pathology and Laboratory Medicine
Director, Parker Institute for Cancer Immunotherapy
Perelman School of Medicine
University of Pennsylvania
Nancy Simonian, MD
President and Chief Executive Officer
Syros Pharmaceuticals
PANEL 2
COVID-19 Vaccine Development and the Enduring Impact on Life Sciences Innovation – Speed, Collaboration, Clinical Trial Advancement and Manufacturing
12:00 pm – 1:00 pm
Co-Moderators:
Joel S. Marcus
Co-Founder, Alexandria Summit;
Executive Chairman & Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments
Lynne Zydowsky, PhD
President & Co-Founder, Alexandria Summit;
Chief Science Officer, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments
Panelists:
Stéphane Bancel
Chief Executive Officer
Moderna, Inc.
Paul Stoffels, MD
Executive Vice President, Chief Scientific Officer
Johnson & Johnson
PANEL 3
The Next 50 Years of Innovation: Where Will It Come From and How Do We Secure It?
(CEOs panel)
1:00 pm – 2:00 pm
Co-Moderators:
Pr. Sue Desmond-Hellmann, MD, MPh
Former Chief Executive Officer
Bill & Melinda Gates Foundation, Seattle, WA
Committee Chair, Prix Galien USA
Co-Chair, Galien Forum
Dr. Michael Rosenblatt
Co-Chair, Galien Forum
Committee Member, Prix Galien USA
Chief Medical Officer
Flagship Pioneering, Cambridge, MA
Panelists:
Kenneth C. Frazier
Chairman of the Board, President and Chief Executive Officer
Merck & Co., Inc.
Betsy Nabel, MD
President
Brigham Health
Michel Vounatsos
Chief Executive Officer
Biogen
PANEL 4
The Future of Therapeutics: What Novel Modalities Will Be Drugs? What Vaccines and Technologies Will We Need?
2:00 pm – 3:30 pm
Chair:
Mikael Dolsten, MD, PhD
Chief Scientific Officer and President
Worldwide Research, Development and Medical
Pfizer Inc.
Panelists:
Penny M. Heaton, MD
Chief Executive Officer
The Bill & Melinda Gates Medical Research Institute
Dean Li, MD, PhD
Senior Vice President Discovery Sciences and Translational Medicine
Merck
John Maraganore, PhD
Chief Executive Officer
Alnylam
Jeff Spaeder, MD
Global Chief Medical & Scientific Officer
IQVIA
George Scangos, PhD
Chief Executive Officer
Vir Biotechnology
Prof. Mads Krogsgaard Thomsen, DVM, PhD, DSc
Executive Vice President and Chief Scientific Officer
Novo Nordisk A/S
CLOSING REMARKS
Pr. Sue Desmond-Hellmann, MD, MPh
Former Chief Executive Officer
Bill & Melinda Gates Foundation, Seattle, WA
Committee Chair, Prix Galien USA
Co-Chair, Galien Forum